Rescue experiments demonstrated that IGF2BP3 is a crucial target of miR-34a in GC because IGF2BP3 re-overexpression partly relieved the tumor-suppressive effect of miR-34a. This evidence concerns the gene IGF2BP3 and gastric cancer.